跳至主要内容
临床试验/NCT02336529
NCT02336529Unknown3 期

Tenderpoint and Ultrasound Guided Nerveblocks for Persistent Pain After Breast Cancer Surgery

Kenneth Geving Andersen0 个研究点目标入组 48 人开始时间: 2016年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
48
主要终点
Summed pain intensity

研究概览

简要总结

Persistent pain after breast cancer surgery (PPBCS) affects 25-60% of breast cancer survivors and nerve damage has been implicated as the cause of this neuropathic pain condition. Local anaesthetic blockade of tenderpoints and the intercostobrachial nerve (ICBN) could provide clues to pathophysiological mechanisms as well as aiding diagnosis and treatment of PPBCS but has never been attempted. The aims of this study is to examine clinical effect of ultrasound guided blockades of the ICBN and tenderpoints of pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • At least 1 year after surgery for breast cancer
  • Women aged 18 or over
  • Suffering from persistent pain in the breast, side of chest, axilla or arm (NRS 4 or over)

排除标准

  • Previous cosmetic surgery
  • bilateral cancer
  • pregnant or lactating
  • other disease in the nervous system
  • in treatment for psychiatric disease
  • unable to understand Danish
  • unable to give informed concent

研究组 & 干预措施

ICBN, active

Experimental

Ultrasound guided injection of bupivacain, 10mL, 0.5% in proximity of the ICBN

干预措施: Bupivacaine (Drug)

ICBN, placebo

Placebo Comparator

Ultrasound guided injection of NaCl, 10mL in proximity of the ICBN

干预措施: NaCl (Drug)

Tenderpoint, active

Experimental

Ultrasound guided injection of bupivacain, 20mL, 0.25% in the tenderpoint

干预措施: Bupivacaine (Drug)

Tenderpoint, placebo

Placebo Comparator

Ultrasound guided injection of NaCl, 20mL in the tenderpoint

干预措施: NaCl (Drug)

结局指标

主要结局

Summed pain intensity

时间窗: At least 1 year after surgery

The summed pain intensity (of pain at rest (0-10), pain during movement (0-10) and pressure pain (at 100kPa in point of maximum pain) (0-10)) 0-30

次要结局

  • Pain at rest, pain during movement and pressure pain(At least 1 year after surgery)
  • Pain related reduction of physical function(At least 1 year after surgery)

研究者

发起方
Kenneth Geving Andersen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kenneth Geving Andersen

Research fellow

Rigshospitalet, Denmark

相似试验